Skip to content

PTSD: all studies

Page 75 of 210: studies 741 to 750 of 2,096, newest first. Back to the PTSD overview

Research

Clinical indicators of the suicide crisis and response to ketamine.

Journal of Affective Disorders March 1, 2025 Elizabeth D. Ballard, Lucinda Neely, Laura Waldman et al. 4 citations

This analysis sought to identify potential clinical targets for the suicide crisis. Characteristics of a useful clinical target include elevation at the time of suicide crisis and responsiveness to rapid-acting interventions. Suicidal ideation (SI), depression, and hopelessness were hypothesized to meet these criteria. Participants were 118 adults across the continuum of suicide risk, including...

MDMA-assisted therapy: challenges, clinical trials, and the future of MDMA in treating behavioral disorders.

CNS Spectrums January 30, 2025 Steve O'Brien, David Nutt 5 citations

This chapter explores the complex and controversial path of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) and other behavioral disorders. It covers MDMA's history from research to recreation to medicine, the pivotal trials, and the challenges faced by researchers. Despite recent setbacks for the clinical application of MDMA, the chapter argues that it holds...

Mindfulness-Oriented Professional Resilience (MOPR) Training to Reduce Compassion Fatigue in Healthcare Workers: A Pilot Study.

Healthcare January 7, 2025 Fabio D'Antoni, Alessio Matiz, Cristiano Crescentini

Background/Objectives: Compassion Fatigue (CF) is a critical issue among healthcare professionals, exacerbated by exposure to trauma and chronic workplace stress. This pilot study evaluates the effectiveness of a Mindfulness-Oriented Professional Resilience (MOPR) program, a structured intervention designed to mitigate CF and enhance resilience in healthcare professionals. The program...

Peculiarities of psycho-emotional and neurovegetative state in Ukrainian women who have experienced war-related stress and ways of its non-medicinal correction.

Wiadomosci lekarskie (Warsaw, Poland : 1960) 2025 Viktor S Matsyshyn, Kostiantyn O Apykhtin, Anatolii M Kravchenko et al.

Aim: To investigate the peculiarities of psycho-emotional and neurovegetative disorders in women exposed to war-related stress and to assess the possibilities of their correction by cognitive behavioural therapy (CBT) and Transcendental Meditation (TM). Materials and Methods: The study involved 72 women, 35 of whom had experienced high-intensity stress and 37 of whom were in the control group....

MDMA and MDMA-Assisted Therapy.

American Journal of Psychiatry 2025 Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray et al. 47 citations

MDMA (i.e., 3,4-methylenedixoymethamphetamine), commonly known as "Ecstasy" or "Molly," has been used since the 1970s both in recreational and therapeutic settings. The Food and Drug Administration (FDA) designated MDMA-Assisted Therapy (MDMA-AT) as a Breakthrough Therapy for posttraumatic stress disorder (PTSD) in 2017, and the FDA is requiring an additional phase 3 trial after rejecting the...

Efficacy of fluoxetine and (R,S)-ketamine in attenuating conditioned fear behaviors in male mice.

Journal of Pharmacology and Experimental Therapeutics 2025 Megan Wells, Jan Hoffmann, Autumn Stage et al. 1 citation

Post-traumatic stress disorder (PTSD) is caused by exposure to a traumatic or stressful event. Symptoms related to this disorder include persistent re-experiencing of memories and fear of generalization. Current pharmacological treatments for PTSD are insufficient, with fewer than 30% of patients reporting symptom remission. This study aims to determine the efficacy of acute (R,S)-ketamine and...

Biological treatments for co-occurring eating disorders and psychological trauma: a systematic review.

Frontiers in Psychiatry 2025 Ella van Beers, Irene de Vries, Caroline Planting et al. 2 citations

Many people with eating disorders report having experienced childhood maltreatment or a traumatic event prior to developing an eating disorder. Although many people with eating disorders have significant traumatic exposure or symptoms of post-traumatic stress disorder, very little research has examined the effects of combined treatments for this group. The purpose of this systematic review was...

Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine.

Frontiers in Psychiatry 2025 Muneeb Hashmi, Padmasini Mugunthan, Priyal Jain et al. 2 citations

Psychogenic non-epileptic seizures (PNES), or functional seizures (FS), are episodes that resemble epileptic seizures but may be psychological in origin. Unlike epileptic seizures, which are linked to abnormal electrical activity in the brain, functional seizures may be associated with psychological and/or physical distress, and do not show the same electrical patterns on an...

Nightmare frequency is a risk factor for suicidal ideation during the COVID-19 pandemic.

Journal of Sleep Research October 1, 2024 Courtney J Bolstad, Brigitte Holzinger, Serena Scarpelli et al.

The association between nightmare frequency (NMF) and suicidal ideation (SI) is well known, yet the impact of the COVID-19 pandemic on this relation is inconsistent. This study aimed to investigate changes in NMF, SI, and their association during the COVID-19 pandemic. Data were collected in 16 countries using a harmonised questionnaire. The sample included 9328 individuals (4848 women; age...

Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells.

Neuron September 25, 2024 Ming Li, Xue-Ke Yang, Jian Yang et al. 30 citations

Erasing traumatic memory during memory reconsolidation is a promising retrieval-extinction strategy for post-traumatic stress disorder (PTSD). Here, we developed an acute social defeat stress (SDS) mouse model with short-term and re-exposure-evoked long-term social avoidance. SDS-associated traumatic memories were identified to be stored in basolateral amygdala (BLA) engram cells. A single...